News

VolparaEnterprise will Help Compliance with FDA’s EQUIP

VolparaEnterprise Software Launched to Help Deliver High-Quality, Personalized Breast Screening

Volpara Health Technologies to List on Australian Stock Exchange (ASX) after Successfully Closing IPO

Volpara Lodges Prospectus for Capital Raising to Take Cancer Detection Software Global

Volpara Solutions in breast density research collaboration with Chinese researchers

Breast Imaging Industry Veteran Julian Marshall Joins Volpara Solutions as Chief Marketing Officer

Volpara Solutions Receives FDA Clearance for Volpara Density Maps

Volpara Solutions Appoints Industry Veteran Mark Koeniguer as Chief Commercial Officer

VolparaDensity Goes Mobile with Installation at Saint Joseph Hospital in Denver

RSNA Research Shows VolparaDensity Central to Quantifying Masking Risk and Optimizing Adjunctive Imaging